FDA approves generic version of Merck's Elestat ophthalmic solution

Perrigo's, PharmaForce/Luitpold's epinastine hydrochloride approved

ALLEGAN, Mich. — The Food and Drug Administration has approved a drug made by Perrigo and PharmaForce/Luitpold Pharmaceuticals for treating eye allergies, Perrigo said.

The FDA approved epinastine hydrochloride ophthalmic solution in the 0.05% strength. The drug is a generic version of Merck's Elestat, used to treat ocular itching related to allergic conjunctivitis.

Annual sales for the branded version before the appearance of generics on the market were $30 million, according to Wolters Kluwer.

Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

Login or Register to post a comment.